Skip to main content
Premium Trial:

Request an Annual Quote

CLC bio, Danish Researchers to Develop Next-Gen Sequencing Software

NEW YORK (GenomeWeb News) – CLC bio said today it will work with researchers at several Danish institutes to develop user-friendly software designed to handle data from-next generation sequencing technologies.
 
The company said it has established the SEQNET network, which will initially operate for three years, using $3 million from the Danish Agency for Science Technology and Innovation.
 
Roald Forsberg, senior scientific officer at CLC bio, said the company will work with its partners to develop graphical user interfaces, algorithms, and high-performance computing solutions. Forsberg said new platforms from 454 Life Sciences, Illumina, and Applied Biosystems “has given rise to a plethora of novel applications for DNA sequencing and has dramatically increased the ambitions of existing projects.”
 
The other SEQNET partners include the Department of Life Sciences at Aalborg University, the Faculty of Agricultural Sciences at Aarhus University, the Department of Biology at the University of Copenhagen, the University of Southern Denmark, and the Aalborg University Hospital.
 
The company said that it plans to develop a “significant amount of new or optimized bioinformatics algorithms” that will be used to help analyze sequencing data from corporate, public, and private research groups.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.